212 related articles for article (PubMed ID: 24990163)
21. Novel reporter T-cell line highly susceptible to both CCR5- and CXCR4-using human immunodeficiency virus type 1 and its application to drug susceptibility tests.
Miyake H; Iizawa Y; Baba M
J Clin Microbiol; 2003 Jun; 41(6):2515-21. PubMed ID: 12791875
[TBL] [Abstract][Full Text] [Related]
22. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 replicates and persists in vaginal epithelial dendritic cells.
Pena-Cruz V; Agosto LM; Akiyama H; Olson A; Moreau Y; Larrieux JR; Henderson A; Gummuluru S; Sagar M
J Clin Invest; 2018 Aug; 128(8):3439-3444. PubMed ID: 29723162
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
25. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.
Popik W; Pitha PM
J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270
[TBL] [Abstract][Full Text] [Related]
27. Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
Soulié C; Tubiana R; Simon A; Lambert-Niclot S; Malet I; Canestri A; Brunet C; Murphy R; Katlama C; Calvez V; Marcelin AG
J Acquir Immune Defic Syndr; 2009 May; 51(1):60-4. PubMed ID: 19390328
[TBL] [Abstract][Full Text] [Related]
28. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
[TBL] [Abstract][Full Text] [Related]
29. Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.
Connell BJ; Hermans LE; Wensing AMJ; Schellens I; Schipper PJ; van Ham PM; de Jong DTCM; Otto S; Mathe T; Moraba R; Borghans JAM; Papathanasopoulos MA; Kruize Z; Venter FWD; Kootstra NA; Tempelman H; Tesselaar K; Nijhuis M
Sci Rep; 2020 Sep; 10(1):15866. PubMed ID: 32985522
[TBL] [Abstract][Full Text] [Related]
30. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
31. Syndecan 4 Upregulation on Activated Langerhans Cells Counteracts Langerin Restriction to Facilitate Hepatitis C Virus Transmission.
Nijmeijer BM; Eder J; Langedijk CJM; Kaptein TM; Meeussen S; Zimmermann P; Ribeiro CMS; Geijtenbeek TBH
Front Immunol; 2020; 11():503. PubMed ID: 32292405
[TBL] [Abstract][Full Text] [Related]
32. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
Grivel JC; Margolis LB
Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
[TBL] [Abstract][Full Text] [Related]
33. Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction.
Hertoghs N; Nijmeijer BM; van Teijlingen NH; Fenton-May AE; Kaptein TM; van Hamme JL; Kappes JC; Kootstra NA; Hahn BH; Borrow P; Ribeiro CMS; Geijtenbeek TBH
PLoS One; 2019; 14(12):e0226651. PubMed ID: 31856198
[TBL] [Abstract][Full Text] [Related]
34. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.
Kawamura T; Cohen SS; Borris DL; Aquilino EA; Glushakova S; Margolis LB; Orenstein JM; Offord RE; Neurath AR; Blauvelt A
J Exp Med; 2000 Nov; 192(10):1491-500. PubMed ID: 11085750
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines.
Mariani SA; Brigida I; Kajaste-Rudnitski A; Ghezzi S; Rocchi A; Plebani A; Vicenzi E; Aiuti A; Poli G
Blood; 2012 Mar; 119(9):2013-23. PubMed ID: 22234680
[TBL] [Abstract][Full Text] [Related]
36. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4.
Esté JA; Cabrera C; Blanco J; Gutierrez A; Bridger G; Henson G; Clotet B; Schols D; De Clercq E
J Virol; 1999 Jul; 73(7):5577-85. PubMed ID: 10364306
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.
de Jong MA; Geijtenbeek TB
J Intern Med; 2009 Jan; 265(1):18-28. PubMed ID: 19093957
[TBL] [Abstract][Full Text] [Related]
38. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
39. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
Terahara K; Ishige M; Ikeno S; Okada S; Kobayashi-Ishihara M; Ato M; Tsunetsugu-Yokota Y
Microbes Infect; 2015 May; 17(5):378-86. PubMed ID: 25839960
[TBL] [Abstract][Full Text] [Related]
40. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses.
Fernàndez G; Llano A; Esgleas M; Clotet B; Esté JA; Martínez MA
J Gen Virol; 2006 May; 87(Pt 5):1285-1294. PubMed ID: 16603531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
